Generated: December 12, 2017
DrugPatentWatch Database Preview
Cefaclor - Generic Drug Details
« Back to Dashboard
What are the generic sources for cefaclor and what is the scope of cefaclor freedom to operate?
is the generic ingredient in four branded drugs marketed by Lilly, Ceph Intl, Dava Pharms Inc, Hikma, Ivax Sub Teva Pharms, Ranbaxy, Teva, Watson Labs Inc, Yung Shin Pharm, Facta Farma, Ranbaxy Labs Ltd, and World Gen, and is included in thirty-three NDAs. Additional information is available in the individual branded drug profile pages.
There are thirteen drug master file entries for cefaclor. Eleven suppliers are listed for this compound.
Pharmacology for cefaclor
Medical Subject Heading (MeSH) Categories for cefaclor
|Lilly||CECLOR CD||cefaclor||TABLET, EXTENDED RELEASE;ORAL||050673-001||Jun 28, 1996||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Dava Pharms Inc||CEFACLOR||cefaclor||CAPSULE;ORAL||064107-002||Apr 27, 1995||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Dava Pharms Inc||CEFACLOR||cefaclor||FOR SUSPENSION;ORAL||064114-001||Apr 28, 1995||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Yung Shin Pharm||CEFACLOR||cefaclor||FOR SUSPENSION;ORAL||065412-004||Feb 17, 2012||AB||RX||No||Yes||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|World Gen||CEFACLOR||cefaclor||TABLET, EXTENDED RELEASE;ORAL||065057-001||Jan 5, 2001||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Ivax Sub Teva Pharms||CEFACLOR||cefaclor||FOR SUSPENSION;ORAL||064070-001||Apr 28, 1995||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Lilly||CECLOR||cefaclor||CAPSULE;ORAL||050521-002||Approved Prior to Jan 1, 1982||DISCN||Yes||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Yung Shin Pharm||CEFACLOR||cefaclor||FOR SUSPENSION;ORAL||065412-002||Feb 17, 2012||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Facta Farma||CEFACLOR||cefaclor||FOR SUSPENSION;ORAL||062206-003||Apr 20, 1988||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Ranbaxy Labs Ltd||RANICLOR||cefaclor||TABLET, CHEWABLE;ORAL||065092-002||Dec 22, 2003||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.